Categories

You can filter the research news archive by selecting one or multiple categories from the following list.






















  Show all news

 

15 May 2019

Testosterone therapy to prevent type 2 diabetes in men at risk - rationale

Testosterone therapy to prevent type 2 diabetes in men at risk - rationale

The “Testosterone 4 Diabetes Mellitus” study, also known as the T4DM trial, is a large study designed to find out if testosterone therapy combined with lifestyle intervention (Weight Watchers®) for 2 years vs. lifestyle intervention alone, improves glucose tolerance and reduces incidence of type 2 diabetes.

The T4DM trial will be the first ever study to specifically investigate the effects of testosterone therapy on motivation and telomere length, a biomarker of aging.

The first results from the T4DM study are expected to get published end of 2019. The T4DM study is a milestone study because it may have significant implications for the treatment of men with type2 diabetes and the diagnosis of hypogonadism.


Last updated: 2019
G.MKT.GM.MH.02.2018.0506